Literature DB >> 3098740

Temporal aspects of O-glycosylation and cell surface expression of ascites sialoglycoprotein-1, the major cell surface sialomucin of 13762 mammary ascites tumor cells.

J Spielman, N L Rockley, K L Carraway.   

Abstract

We have investigated the biosynthesis and cell surface expression of the major cell surface sialomucin (ascites sialoglycoprotein-1 (ASGP-1] of 13762 rat mammary ascites tumor cells by pulse or pulse-chase metabolic labeling combined with precipitation with peanut agglutinin and alkaline borohydride elimination or proteolytic fragmentation. The minimum time for initial glycosylation was estimated from the time required for the protein to acquire the ability to bind to peanut agglutinin to be less than 5 min. Moreover, when cells were labeled with threonine for 5 min and the ASGP-1 isolated by peanut agglutinin precipitation, 3% of the labeled threonine could be converted to 2-aminobutyric acid by alkaline borohydride elimination of the carbohydrate, indicating that at least 3% of the threonines of ASGP-1 are O-glycosylated within 5 min of polypeptide synthesis. The minimum time between the final glycosylation reactions in the cell and appearance of ASGP-1 at the cell surface was determined by trypsinizing galactose- or glucosamine-labeled cells at timed intervals after labeling to occur within 5-10 min of labeling. Both labeled glucosamine and galactosamine appeared in ASGP-1 fragments within 5 min, but the amount of labeled galactosamine was less than the amount of labeled glucosamine until after 20 min, when the 1:1 equilibrium ratio was reached. The half-time for appearance of glucosamine-labeled ASGP-1 at the cell surface was found to be greater than 4 h. The minimum time required from synthesis of the ASGP-1 polypeptide to appearance at the cell surface was determined by leucine labeling and proteolysis to be 70-80 min. These combined studies suggest a continuum of O-linked oligosaccharide initiation events extending over most of the period of ASGP-1 biosynthesis and transit from the endoplasmic reticulum to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098740

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Cloning and characterization of gp36, a human mucin-type glycoprotein preferentially expressed in vascular endothelium.

Authors:  G Zimmer; F Oeffner; V Von Messling; T Tschernig; H J Gröness; H D Klenk; G Herrler
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

2.  Temporal aspects of O-glycosylation of glycoprotein C from herpes simplex virus type-1.

Authors:  F Serafini-Cessi; F Dall'Olio; N Malagolini; G Campadelli-Fiume
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

3.  Amino acid distributions around O-linked glycosylation sites.

Authors:  I B Wilson; Y Gavel; G von Heijne
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

4.  Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus.

Authors:  R A Olmsted; B R Murphy; L A Lawrence; N Elango; B Moss; P L Collins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  Cloning and characterization of the 5' flanking region of the sialomucin complex/rat Muc4 gene: promoter activity in cultured cells.

Authors:  S A Price-Schiavi; A Perez; R Barco; K L Carraway
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

6.  Biosynthesis of mucin derived from a 60-kDa precursor protein in the human stomach.

Authors:  S Sano; K Okazaki; Y Yamamoto; A Slomiany; B L Slomiany
Journal:  J Gastroenterol       Date:  1994-12       Impact factor: 7.527

7.  Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.

Authors:  E Osinaga; G Pancino; N Porchet; N Berois; P De Cremoux; D Mistro; J P Aubert; F Calvo; A Roseto
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Synthesis and secretion of mucin by the human colonic tumour cell line LS180.

Authors:  D J McCool; J F Forstner; G G Forstner
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

9.  Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors.

Authors:  K Kozarsky; D Kingsley; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 10.  The role of membrane mucin MUC4 in breast cancer metastasis.

Authors:  Courtney A Dreyer; Kacey VanderVorst; Savannah Free; Ashley Rowson-Hodel; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2021-11-24       Impact factor: 5.678

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.